HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr. Oz As Role Model? No Defense Against FTC Action On Weight Loss Claims

This article was originally published in The Rose Sheet

Executive Summary

Weight loss supplement Pure Green Coffee marketer demonstrated “reckless indifference” in marketing the product, beginning after learning about the benefits of green coffee bean on The Dr. Oz Show, a federal judge says.

You may also be interested in...



Supplement Industry Summit Postponed, But Sales Jump As Consumers Respond To Covid-19

Dietary Supplements Regulatory Summit scheduled for 27 May in Washington is postponed. Even as supplies from China are slowed or interrupted due to Covid-19, though, sales of some consumer health products jump as consumers respond to the public health threat.

Complaint Alleges Dr. Oz 'Magic' Ingredient Promotion Touches Products

A class action complaint says TV personality Dr. Mahmet Oz made “miracle” fat busting claims for supplement ingredients that were “patently false” and misled consumers into purchasing products. The complaint also targets marketers of Labrada weight loss formulas and supplement ingredient suppliers.

FTC Members Spar Over ‘Protected’ Speech On ‘Dr. Oz’ In Supplement Claims Enforcement

FTC announces a settlement including $9 million in consumer redress for false ads for green coffee extract supplements. In a dissent, Commissioners Maureen Ohlhausen and Joshua Wright argue that comments made in TV programs are “protected non-commercial speech” and should not influence the amount of a fine.

Related Content

Topics

UsernamePublicRestriction

Register

GB150348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel